First bee vaccine

DOI: https://doi.org/10.1038/s41587-023-01694-y
IF: 46.9
2023-02-16
Nature Biotechnology
Abstract:Like other insects, honeybees don't generate antibodies, so until recently they have been overlooked in the quest for vaccines. Dalan's founder Dalial Freitak, a researcher at the University of Graz, Austria, showed in 2015 that honeybees have a specific immune-priming glycoprotein called vitellogenin, which is also a precursor for egg-yolk proteins. Vitellogenin binds to bacteria-derived molecules — such as lipopolysaccharides and peptidoglycan — and once ingested transports them via the circulatory system into the queen's eggs, thus immunizing an entire colony. Efficacy studies published in 2022 showed that Dalan's vaccine reduces larval death by 30–50%, enough to stop the disease from manifesting in hives. Dalan is also developing vaccines for European foulbrood, caused by the bacterium Melissococcus plutonius , and the fungal disease chalkbrood in honeybees, and holds patents describing vaccination in other economically important insects such as silkworms.
biotechnology & applied microbiology
What problem does this paper attempt to address?